These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 319474)

  • 1. Acute versus chronic effects of monoamine oxidase inhibitors in depressed patients: time course of MAO inhibitors [proceedings].
    Robinson DS; Nies A; Ravaris CL
    Psychopharmacol Bull; 1977 Jan; 13(1):50-1. PubMed ID: 319474
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls.
    Nies A; Robinson DS; Harris LS; Lamborn KR
    Adv Biochem Psychopharmacol; 1974; 12(0):59-70. PubMed ID: 4607593
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics of monoamine oxidase.
    Robinson DS; Nies A
    Mod Probl Pharmacopsychiatry; 1975; 10():57-64. PubMed ID: 1101048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of depression with an mao inhibitor followed by 5-HTP--an unfinished research project.
    Kline N; Sacks W
    Acta Psychiatr Scand Suppl; 1980; 280():233-41. PubMed ID: 6996430
    [No Abstract]   [Full Text] [Related]  

  • 5. MAO inhibitors and platelet MAO inhibition.
    Giller E; Lieb J
    Commun Psychopharmacol; 1980; 4(1):79-82. PubMed ID: 7398245
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M; Poltyrev T; Bejar C; Youdim MB
    Psychopharmacology (Berl); 2002 Mar; 160(3):318-24. PubMed ID: 11889501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of tricyclic antidepressant-mediated inhibition of platelet monoamine oxidase.
    Sullivan JL; Zung WW; Stanfield CN; Cavenar JO
    Biol Psychiatry; 1978 Jun; 13(3):399-407. PubMed ID: 667237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol inhibition of monoamine oxidase in vivo and in vitro.
    Giller E; Hall H; Reubens L; Wojciechoswki J
    Biol Psychiatry; 1984 Apr; 19(4):517-23. PubMed ID: 6733172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of moclobemide on clinical and neurochemical variables in depressed patients (preliminary findings).
    Stefanis CN; Alevizos B; Markianos M; Hatzimanolis J
    J Neural Transm Suppl; 1988; 26():87-95. PubMed ID: 2452231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAO inhibitors in clinical practice: principles based on recent research [proceedings].
    Nies A; Robinson DS; Bartlett D; Lamborn KR
    Psychopharmacol Bull; 1977 Jan; 13(1):54-5. PubMed ID: 319475
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAO inhibitors.
    Keller D
    Cleve Clin J Med; 2011 Feb; 78(2):81; author reply 81. PubMed ID: 21365960
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J; McLeod MN; White HL
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a selective inhibitor of type A monoamine oxidase--Lilly 51641--on behavior, sleep and circadian rhythms in depressed and schizophrenic patients.
    Carman JS; Gillin JC; Murphy DL; Weinberger DR; Kleinman JE; Bigelow LB; Wyatt RJ
    Commun Psychopharmacol; 1978; 2(6):513-23. PubMed ID: 371909
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
    Ponto LB; Perry PJ; Liskow BI; Seaba HH
    Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of MAO studies in psychiatry].
    Matsumoto H
    Psychiatr Pol; 1978; 12(3):419-28. PubMed ID: 358242
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical chemistry of monoamine oxidase.
    Glover V; Sandler M
    Cell Biochem Funct; 1986 Apr; 4(2):89-97. PubMed ID: 3486724
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of monoamine oxidase.
    Tipton KF
    Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):361-7. PubMed ID: 4058103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.